NASDAQ:AZTA

Azenta Stock News

Healthcare > Medical - Instruments & Supplies

Buy AZTA

*Your capital is at risk

$23.89

+0.460 (+1.96%)

At Close: Jun 03, 2026

Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research

04:05pm, Tuesday, 04'th Jun 2024

Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries BURLINGTON, Mass.

Azenta to Participate in the Jefferies Global Healthcare Conference

04:05pm, Thursday, 23'rd May 2024

BURLINGTON, Mass. , May 23, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Global Healthcare Conference in New York, NY, on

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by